Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders

Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788 · see citing works

Enzymatic O-methylation of epinephrine and other catechols

Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283 · see citing works

Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme

Lotta, T. I., Vidgren, J., Tilgmann, C., Ulmanen, I., Melén, K., Julkunen, I., & Taskinen, J. (1995) · Biochemistry · doi:10.1021/bi00013a008 · Cited by 1,167 · see citing works

Functional role of estrogen metabolism in target cells: review and perspectives

Zhu, B. T. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 964 · see citing works

Age at first birth and breast cancer risk.

MacMahon, B., Cole, P. T., Lin, T. M., Lowe, C. R., Mirra, A. P., Ravnihar, B., Salber, E. J., Valaoras, V. G., & Yuasa, S. (1970) · Europe PMC (PubMed Central) · Cited by 878 · see citing works

Catechol- <i>O</i> -methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior

Gogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864 · see citing works

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

Fotsis, T., Zhang, Y., Pepper, M. S., Adlercreutz, H., Montesano, R., Nawroth, P. P., & Schweigerer, L. (1994) · Nature · doi:10.1038/368237a0 · Cited by 730 · see citing works

Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators

Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorović, R., Dwivedy, I., Higginbotham, S. M., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10937 · Cited by 728 · see citing works

17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.

Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., & Sutter, T. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9776 · Cited by 631 · see citing works

Catecholamine metabolism: basic aspects and clinical significance.

Kopin, I. J. (1985) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06859-0 · Cited by 582 · see citing works

Catechol-O-Methyl Transferase: Pharmacological Aspects and Physiological Role

Guldberg, H. C., & Marsden, C. A. (1975) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06681-5 · Cited by 557 · see citing works

Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.

Klauber, N., Parangi, S., Flynn, E. A., Hamel, E., & D’Amato, R. J. (1997) · PubMed · Cited by 524 · see citing works

Characterization of 21 newly established esophageal cancer cell lines

Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N., & Tobe, T. (1992) · Cancer · doi:10.1002/1097-0142(19920115)69:2 · Cited by 494 · see citing works

Estrogens and breast cancer.

Feigelson, H., & Henderson, B. (1996) · Carcinogenesis · doi:10.1093/carcin/17.11.2279 · Cited by 416 · see citing works

2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site.

D’Amato, R. J., Lin, C. M., Flynn, E. A., Folkman, J., & Hamel, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3964 · Cited by 407 · see citing works

Crystal structure of catechol O-methyltransferase

Vidgren, J., Svensson, L., & Liljas, A. (1994) · Nature · doi:10.1038/368354a0 · Cited by 403 · see citing works

Bipolar spectrum disorders in patients diagnosed with velo-cardio- facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

Papolos, D. F., Faedda, G. L., Veit, S., Goldberg, R. B., Morrow, B. E., Kucherlapati, R., & Shprintzen, R. J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1541 · Cited by 357 · see citing works

Pharmacokinetics of Levodopa

Nutl, J. G., & Fellman, J. H. (1984) · Clinical Neuropharmacology · doi:10.1097/00002826-198403000-00002 · Cited by 357 · see citing works

Carcinogenicity of catechol estrogens in Syrian hamsters

Liehr, J. G., Wan-Fen, F., Sirbasku, D. A., & Ari-Ulubelen, A. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90080-4 · Cited by 356 · see citing works

Genomic organization of the human catechol <i>O</i>‐methyltransferase gene and its expression from two distinct promoters

TENHUNEN, J., SALMINEN, M., LUNDSTRÖM, K., KIVILUOTO, T., SAVOLAINEN, R., & ULMANEN, I. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb19083.x · Cited by 331 · see citing works

Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations

Rinne, U. K., Larsen, J. O., Sidén, Å., Worm-Petersen, J., & The Nomecomt Study Group* (1998) · Neurology · doi:10.1212/wnl.51.5.1309 · Cited by 326 · see citing works

Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells

Spink, D. C. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.291 · Cited by 310 · see citing works

Entacapone improves motor fluctuations in levodopa‐ treated Parkinson's disease patients

(1997) · Annals of Neurology · doi:10.1002/ana.410420511 · Cited by 308 · see citing works

Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice

Bradlow, H. L., Michnovicz, J. J., TELANG, N. T., et al. (1991) · Carcinogenesis · doi:10.1093/carcin/12.9.1571 · Cited by 307 · see citing works

Genotype determining low catechol- <i>O</i> -methyltransferase activity as a risk factor for obsessive-compulsive disorder

Karayiorgou, M., Altemus, M., Galke, B. L., Goldman, D., Murphy, D. L., Ott, J., & Gogos, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4572 · Cited by 304 · see citing works

Free radical generation by redox cycling of estrogens

Liehr, J. G., & Roy, D. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90108-u · Cited by 298 · see citing works

Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1→q11.2

Grossman, M. H., Emanuel, B. S., & Budarf, M. L. (1992) · Genomics · doi:10.1016/0888-7543(92)90316-k · Cited by 296 · see citing works

An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.

Lavigne, J. A., Helzlsouer, K. J., Huang, H. Y., et al. (1997) · PubMed · Cited by 283 · see citing works

Interactions Between Estrogens and Catechol Amines III. Studies on the Methylation of Catechol Estrogens, Catechol Amines and other Catechols by the Catechol-<i>O</i>-Methyltransferase1 of Human Liver

BALL, P., KNUPPEN, R., HAUPT, M., & BREUER, H. (1972) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem-34-4-736 · Cited by 280 · see citing works

Estrogen Metabolism and Excretion in Oriental and Caucasian Women

Adlercreutz, H., Gorbach, S. L., Goldin, B. R., Woods, M. N., Dwyer, J. T., & Hämäläinen, E. K. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.14.1076 · Cited by 251 · see citing works

Human liver catechol-O-methyltransferase pharmacogenetics

Boudíková, B., Szumlanski, C. L., Maidak, B. L., & Weinshilboum, R. M. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.166 · Cited by 248 · see citing works

Effect of peripheral catechol‐O‐methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

Nutt, J. G., Woodward, W. R., Beckner, R. M., Stone, C. K., Berggren, K., Carter, J. H., Gancher, S. T., Hammerstad, J. P., & Gordin, A. (1994) · Neurology · doi:10.1212/wnl.44.5.913 · Cited by 247 · see citing works

Inheritance of low erythrocyte catechol-o-methyltransferase activity in man.

Weinshilboum, R. M., & Raymond, F. A. (1977) · Europe PMC (PubMed Central) · Cited by 247 · see citing works

Plasma Metanephrines Are Markers of Pheochromocytoma Produced by Catechol- O -Methyltransferase Within Tumors

Eisenhofer, G., Keiser, H. R., Friberg, P., Mezey, É., Huynh, T., Hiremagalur, B., Ellingson, T., Duddempudi, S., Eijsbouts, A. M. M., & Lenders, J. W. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4870 · Cited by 242 · see citing works

Risk factors for breast cancer in Chinese women in Shanghai.

Yuan, J., Yu, M. C., Ross, R. K., Gao, Y., & Henderson, B. E. (1988) · PubMed · Cited by 233 · see citing works

“On‐off” phenomenon with levodopa therapy in parkinsonism

Fahn, S. (1974) · Neurology · doi:10.1212/wnl.24.5.431 · Cited by 230 · see citing works

Genotoxic effects of estrogens

Liehr, J. G. (1990) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(90)90018-7 · Cited by 226 · see citing works

Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism.

Jj, L., & Li, S. A. (1987) · PubMed · Cited by 220 · see citing works

Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior

Strous, R. D., Bark, N. M., Parsia, S. S., Volavka, J., & Lachman, H. M. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)03111-3 · Cited by 217 · see citing works

Biological Properties of 16α-Hydroxyestrone: Implications in Estrogen Physiology and Pathophysiology*

Fishman, J., & Martucci, C. P. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-611 · Cited by 215 · see citing works

4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis.

Liehr, J. G., Ricci, M. J., Jefcoate, C. R., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9220 · Cited by 210 · see citing works

O-Methylation of Catechol Amines in Vivo

Axelrod, J., Senoh, S., & Witkop, B. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64730-1 · Cited by 207 · see citing works

Tolcapone Improves Motor Function and Reduces Levodopa Requirement in Patients with Parkinson's Disease Experiencing Motor Fluctuations

Kurth, M., Adler, C. H., Saint‐Hilaire, M., Singer, C., Waters, C., LeWitt, P. A., CHERNIK, D. A., Dorflinger, E. E., & Yoo, K. (1997) · Neurology · doi:10.1212/wnl.48.1.81 · Cited by 205 · see citing works

Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.

Thompson, P. A., Shields, P. G., Freudenheim, J. L., et al. (1998) · PubMed · Cited by 203 · see citing works

Association Between Catechol O-Methyltransferase Genotype and Violence in Schizophrenia and Schizoaffective Disorder

Lachman, H. M., Nolan, K. A., Mohr, P., Saito, T., & Volavka, J. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.835 · Cited by 198 · see citing works

Dopamine and the Kidney: Ten Years on

Lee, M. R. (1993) · Clinical Science · doi:10.1042/cs0840357 · Cited by 197 · see citing works

Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form.

Bertocci, B., Miggiano, V., Prada, M. D., Dembić, Z., Lahm, H. W., & Malherbe, P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1416 · Cited by 194 · see citing works

Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation

Jellinck, P. H., Gekforkert, P., Riddick, D. S., et al. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90258-x · Cited by 191 · see citing works

Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism

Tiihonen, J., Hallikainen, T., Lachman, H., Saito, T., Volavka, J., Kauhanen, J., Salonen, J. T., Ryynänen, O.-P., Koulu, M., Karvonen, M. K., et al. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000509 · Cited by 189 · see citing works

Synthesis, Antitubulin and Antimitotic Activity, and Cytotoxicity of Analogs of 2-Methoxyestradiol, an Endogenous Mammalian Metabolite of Estradiol That Inhibits Tubulin Polymerization by Binding to the Colchicine Binding Site

Cushman, M., He, H.-M., Katzenellenbogen, J. A., Lin, C. M., & Hamel, E. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00012a003 · Cited by 183 · see citing works

Clearance of Exogenous Dopamine in Rat Dorsal Striatum and Nucleus Accumbens: Role of Metabolism and Effects of Locally Applied Uptake Inhibitors

Cass, W. A., Zahniser, N. R., Flach, K. A., & Gerhardt, G. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07469.x · Cited by 174 · see citing works

Cloning and Characterization of Human Placental Catechol--Methyltransferase cDNA

LUNDSTR, K., Salminen, M., Jalanko, A., Savolainen, R., & Ulmanen, I. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.181 · Cited by 169 · see citing works

Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors

Männistö, P. T., Ulmanen, I., Lundstrom, K. H., Taskinen, J., Tenhunen, J., Tilgmann, C., & Kaakkola, S. (1992) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7144-0_9 · Cited by 168 · see citing works

Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland.

Syvänen, A., Tilgmann, C., Rinne, J., & Ulmanen, I. (1997) · Pharmacogenetics (London) · doi:10.1097/00008571-199702000-00009 · Cited by 168 · see citing works

Tolcapone and fulminant hepatitis

Assal, F., Spahr, L., Hadengue, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(05)61511-5 · Cited by 168 · see citing works

Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenon: A double-blind, placebo-controlled, multicenter trial

Rajput, A. H., Martin, W. R. W., Saint‐Hilaire, M., Dorflinger, E. E., & Pedder, S. C. J. (1997) · Neurology · doi:10.1212/wnl.49.4.1066 · Cited by 168 · see citing works

Cerebral Metabolism of 6–[ 18 F]Fluoro‐l‐3,4‐Dihydroxyphenylalanine in the Primate

Firnau, G., Sood, S. K., Chirakal, R. V., et al. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05629.x · Cited by 167 · see citing works

Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder

Kirov, G., Murphy, K. C., Arranz, M. J., Jones, I. R., McCandles, F., Kunugi, H., Murray, R. M., McGuffin, P., Collier, D. A., Owen, M. J., et al. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000385 · Cited by 167 · see citing works

Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele

Papolos, D. F., Veit, S., Faedda, G. L., Saito, T., & Lachman, H. M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000410 · Cited by 166 · see citing works

Cytochrome P-450-mediated redox cycling of estrogens.

Liehr, J. G., Ulubelen, A. A., & Strobel, H. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75968-7 · Cited by 161 · see citing works

Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance.

Ball, P., & Knüppen, R. (1980) · PubMed · Cited by 158 · see citing works

Catechol- O -Methyltransferase: Thermolabile Enzyme in Erythrocytes of Subjects Homozygous for Allele for Low Activity

Scanlon, P. D., Raymond, F. A., & Weinshilboum, R. M. (1979) · Science · doi:10.1126/science.758679 · Cited by 153 · see citing works

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

Nissinen, E., Lindén, I., Schultz, E., et al. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00173538 · Cited by 148 · see citing works

No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity

Daniels, J. K., Williams, N. M., Williams, J. H., Jones, L. A., Cardno, A. G., Murphy, K. C., Spurlock, G., Riley, B. P., Scambler, P. J., Asherson, P. J., et al. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.2.268 · Cited by 147 · see citing works

Low activity allele of catechol-o-methyltransferase gene and Japanese unipolar depression

Ohara, K., Nagai, M., Suzuki, Y., & Ohara, K. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00009 · Cited by 145 · see citing works

The cytotoxic effects of estradiol-17β, catecholestradiols and methoxyestradiols on dividing MCF-7 and Hela cells

Seegers, J. C., Aveling, M.-L., van Aswegen, C. H., et al. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90455-x · Cited by 145 · see citing works

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

Bäckström, R., Honkanen, E., Pippuri, A., et al. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00124a017 · Cited by 145 · see citing works

Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations.

Ruottinen, H., & Rinne, U. K. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.1.36 · Cited by 145 · see citing works

Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients

Baas, H. K. J., Beiske, A. G., Ghika, J.-A., Jackson, M., Oertel, W. H., Poewe, W. H., & Ransmayr, G. N. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.4.421 · Cited by 144 · see citing works

Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatment

Waters, C., Kurth, M., Bailey, P., et al. (1997) · Neurology · doi:10.1212/wnl.49.3.665 · Cited by 144 · see citing works

The Role of Estrogen in Mammary Carcinogenesisa

Fishman, J., Osborne, M. P., & TELANG, N. T. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb12113.x · Cited by 140 · see citing works

Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's Disease

Männistö, P. T., & Kaakkola, S. (1990) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1990.tb00756.x · Cited by 139 · see citing works

Contribution of Sulfate Conjugation, Deamination, and O‐Methylation to Metabolism of Dopamine and Norepinephrine in Human Brain

Rivett, A. J., Eddy, B. J., & Roth, J. A. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb11490.x · Cited by 136 · see citing works

Randomized, Placebo-Controlled Study of Tolcapone in Patients With Fluctuating Parkinson Disease Treated With Levodopa-Carbidopa

Adler, C. H. (1998) · Archives of Neurology · doi:10.1001/archneur.55.8.1089 · Cited by 136 · see citing works

Neuropharmacology of S-adenosyl-L-methionine

Baldessarini, R. J. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90860-6 · Cited by 134 · see citing works

Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells.

Lottering, M.-L., Haag, M., & Seegers, J. C. (1992) · PubMed · Cited by 132 · see citing works

Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenon

Rajput, A. H., Martin, W. R. W., Saint‐Hilaire, M., Dorflinger, E. E., & Pedder, S. C. J. (1998) · Neurology · doi:10.1212/wnl.50.5_suppl_5.s54 · Cited by 132 · see citing works

Cloning, expression and structure of catechol-O-methyltransferase

Lundstrom, K. H., Tenhunen, J., Tilgmann, C., Karhunen, T., Panula, P., & Ulmanen, I. (1995) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(95)00071-2 · Cited by 131 · see citing works

17β-Estradiol 2- and 4-Hydroxylation Catalyzed by Rat Hepatic Cytochrome P-450: Roles of Individual Forms, Inductive Effects, Developmental Patterns, and Alterations by Gonadectomy and Hormone Replacement*

Dannan, G. A., Porubek, D. J., Nelson, S. D., et al. (1986) · Endocrinology · doi:10.1210/endo-118-5-1952 · Cited by 131 · see citing works

Membrane-bound catechol-O-methyltransferase: A reevaluation of its role in the O-methylation of the catecholamine neurotransmitters

Roth, J. A. (1992) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0036121 · Cited by 128 · see citing works

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase

Kaakkola, S., Gordin, A., & Männistö, P. T. (1994) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)90082-5 · Cited by 128 · see citing works

High and low activity alleles of catechol-O-methyltransferase gene: ethnic difference and possible association with Parkinson's disease

Kunugi, H., Nanko, S., Ueki, A., Otsuka, E., Hattori, M., Hoda, F., Vallada, H., Arranz, M. J., & Collier, D. A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13289-4 · Cited by 128 · see citing works

Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes

Kerlan, V., Dréano, Y., Bercovici, J. P., Beaune, P. H., Floch, H. H., & Berthou, F. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90068-t · Cited by 128 · see citing works

Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone

Ker�nen, T., Gordin, A., Karlsson, M., et al. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00199880 · Cited by 127 · see citing works

Preferential transmission of the high activity allele of COMT in schizophrenia

Li, T., Sham, P. C., Vallada, H., Xie, T., Tang, X., Murray, R. M., Liu, X., & Collier, D. A. (1996) · Psychiatric Genetics · doi:10.1097/00041444-199623000-00005 · Cited by 127 · see citing works

A Double-Blind Pharmacokinetic and Clinical Dose—Response Study of Entacapone as an Adjuvant to Levodopa Therapy in Advanced Parkinson's Disease

Ruottinen, H., & Rinne, U. K. (1996) · Clinical Neuropharmacology · doi:10.1097/00002826-199619040-00001 · Cited by 127 · see citing works

Stereochemical course of the transmethylation catalyzed by catechol O-methyltransferase.

Woodard, R. W., Tsai, M., Floss, H. G., et al. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70536-5 · Cited by 122 · see citing works

Distribution of catechol-O-methyltransferase expression in human central nervous system

Hong, J., Shu-Leong, H., Tao, X., & Lap-Ping, Y. (1998) · Neuroreport · doi:10.1097/00001756-199808240-00033 · Cited by 121 · see citing works

Distribution of catechol-O-methyltransferase enzyme in rat tissues.

Karhunen, T., Tilgmann, C., Ulmanen, I., Julkunen, I., & Panula, P. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.8.8027527 · Cited by 120 · see citing works

New selective COMT inhibitors: useful adjuncts for Parkinson's disease?

Männistö, P. T., & Kaakkola, S. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90075-8 · Cited by 119 · see citing works

[34] Catechol O-methyltransferase

Borchardt, R. T. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)77036-8 · Cited by 118 · see citing works

Molecular cloning and characterization of rat liver catechol-O-methyltransferase

Salminen, M., Lundstrom, K. H., Tilgmann, C., Savolainen, R., Kalkkinen, N., & Ulmanen, I. (1990) · Gene · doi:10.1016/0378-1119(90)90231-f · Cited by 118 · see citing works

Catechol-O-methyltransferase and breast cancer risk

Millikan, R. C. (1998) · Carcinogenesis · doi:10.1093/carcin/19.11.1943 · Cited by 118 · see citing works

Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat

Nissinen, E., Lindén, I., Schultz, E., et al. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90614-0 · Cited by 116 · see citing works

Catechol-O-methyltransferase activity: A determinant of levodopa response

Reilly, D. K., Rivera‐Calimlim, L., & Dyke, D. V. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.161 · Cited by 115 · see citing works

Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in parkinsonian patients

Kaakkola, S., Teräväinen, H., Ahtila, S., et al. (1994) · Neurology · doi:10.1212/wnl.44.1.77 · Cited by 115 · see citing works

Genetics of red cell COMT activity: Analysis of thermal stability and family data

Spielman, R. S., Weinshilboum, R. M., & Opitz, J. M. (1981) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320100311 · Cited by 115 · see citing works

Pharmacokinetic‐pharmacodynamic interaction between the COMT inhibitor tolcapone and single‐dose levodopa.

Dingemanse, J., Jorga, K. M., Zürcher, G., et al. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05781.x · Cited by 114 · see citing works

Uterine estrogen receptor binding of catecholestrogens and of estetrol (1,3,5(10)-estratriene-3,15α,16α,17β-tetrol)

Martucci, C. P., & Fishman, J. (1976) · Steroids · doi:10.1016/0039-128x(76)90054-4 · Cited by 113 · see citing works

Catechol‐O‐methyltransferase‐Inhibiting Pyrocatechol Derivatives: Synthesis and Structure‐Activity Studies

Borgulya, J., Bruderer, H., Bernauer, K., et al. (1989) · Helvetica Chimica Acta · doi:10.1002/hlca.19890720511 · Cited by 113 · see citing works

Effect of L-Dopa and the Catechol-O-Methyltransferase Inhibitor Ro 41–0960 on Sulfur Amino Acid Metabolites in Rats

Miller, J. W., Shukitt‐Hale, B., Villalobos‐Molina, R., et al. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199702000-00007 · Cited by 112 · see citing works

Comparative properties of the catechol estrogens, I: Methylation by catechol-O-methyltransferase and binding to cytosol estrogen receptors

Merriam, G. R., MacLusky, N. J., Picard, M. K., & Naftolin, F. N. (1980) · Steroids · doi:10.1016/0039-128x(80)90062-8 · Cited by 111 · see citing works

The Effect of Catechol-O-Methyl Transferase Inhibition by Entacapone on the Pharmacokinetics and Metabolism of Levodopa in Healthy Volunteers

Keränen, T., Gordin, A., Harjola, V., et al. (1993) · Clinical Neuropharmacology · doi:10.1097/00002826-199304000-00007 · Cited by 110 · see citing works

Distinct Cellular Localization of Membrane‐Bound and Soluble Forms of Catechol‐O‐Methyltransferase in Brain

Rivett, A. J., Francis, A., & Roth, J. A. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb12673.x · Cited by 109 · see citing works

Catechol‐O‐methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients

Roberts, J. W., Cora‐Locatelli, G., Bravi, D., et al. (1993) · Neurology · doi:10.1212/wnl.43.12.2685 · Cited by 107 · see citing works

Identification of Sequence Variants and Analysis of the Role of the Catechol-O-Methyl-Transferase Gene in Schizophrenia Susceptibility

Karayiorgou, M., Gogos, J. A., Galke, B. L., Wolyniec, P. S., Nestadt, G., Antonarakis, S. E., Kazazian, H. H., Housman, D. E., & Pulver, A. E. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00202-3 · Cited by 107 · see citing works

Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans*

Dingemanse, J., Jorga, K. M., Schmitt, M., Gieschke, R., Fotteler, B., Zürcher, G., Prada, M. D., & van Brummelen, P. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90035-7 · Cited by 106 · see citing works

No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene

Kunugi, H., Vallada, H., Hoda, F., Kirov, G., Gill, M., Aitchison, K. J., Ball, D., Arranz, M. J., Murray, R. M., & Collier, D. A. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00366-6 · Cited by 106 · see citing works

Expression and Intracellular Localization of Catechol O‐methyltransferase in Transfected Mammalian Cells

Ulmanen, I., Peränen, J., Tenhunen, J., Tilgmann, C., Karhunen, T., Panula, P., Bernasconi, L., Aubry, J., & Lundstrom, K. H. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0452a.x · Cited by 105 · see citing works

No association between anxiety disorders and catechol-O-methyltransferase polymorphism

Ohara, K., Nagai, M., Suzuki, Y., Ochiai, M., & Ohara, K. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00062-6 · Cited by 105 · see citing works

Inhibition of Catechol O-Methyltransferase-catalyzed O-Methylation of 2- and 4-Hydroxyestradiol by Quercetin

Zhu, B. T., & Liehr, J. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1357 · Cited by 105 · see citing works

Cholinergic-dopaminergic interactions in cognitive performance

Levin, E. D., McGurk, S. R., Rose, J. E., & Butcher, L. L. (1990) · Behavioral and Neural Biology · doi:10.1016/0163-1047(90)90639-n · Cited by 102 · see citing works

Cognitive improvement during Tolcapone treatment in Parkinson's disease

Gasparini, M., Fabrizio, E., Bonifati, V., & Meco, G. (1997) · Journal of Neural Transmission · doi:10.1007/bf01285556 · Cited by 98 · see citing works

Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease.

Merello, M., Lees, A. J., Webster, R. A., Bovingdon, M., & Gordin, A. (1994) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.2.186 · Cited by 98 · see citing works

Different in vivo properties of three new inhibitors of catechol O‐methyltransferase in the rat

Männistö, P. T., Tuomainen, P. M., & Tuominen, R. K. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09020.x · Cited by 98 · see citing works

Formation and Clearance of Interstitial Metabolites of Dopamine and Serotonin in the Rat Striatum: An In Vivo Microdialysis Study

Cumming, P. D., Brown, E. E., Damsma, G., & Fibiger, H. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11026.x · Cited by 98 · see citing works

Kinetic studies on the O-methylation of dopamine by human brain membrane-bound catechol O-methyltransferase

Rivett, A. J., & Roth, J. A. (1982) · Biochemistry · doi:10.1021/bi00537a006 · Cited by 98 · see citing works

The effect of entacapone (OR‐611) on brain [ 18 F]‐6‐L‐fluorodopa metabolism

Sawle, G. V., Burn, D. J., Morrish, P., et al. (1994) · Neurology · doi:10.1212/wnl.44.7.1292 · Cited by 98 · see citing works

Characterization of Membrane‐Bound and Soluble Catechol‐O‐Methyltransferase from Human Frontal Cortex

Jeffery, D., & Roth, J. A. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb02755.x · Cited by 96 · see citing works

Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation.

Li, J. J., Li, S. A., Oberley, T. D., et al. (1995) · PubMed · Cited by 95 · see citing works

Interactions of 2-Methoxyestradiol, an Endogenous Mammalian Metabolite, with Unpolymerized Tubulin and with Tubulin Polymers

Hamel, E., Lin, C. M., Flynn, E. A., et al. (1996) · Biochemistry · doi:10.1021/bi951559s · Cited by 94 · see citing works

Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics

Ohmori, O., Shinkai, T., Kojima, H., Terao, T., Suzuki, T., Mita, T., & Abe, K. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00100-1 · Cited by 92 · see citing works

Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers

van Aswegen, C. H., Purdy, R. H., & Wittliff, J. L. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90380-4 · Cited by 92 · see citing works

Catechol-O-methyltransferase Vall58Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder

Li, T., Vallada, H., Curtis, D., Arranz, M. J., Xu, K., Cai, G., Deng, H., Liu, J., Murray, R. M., Liu, X., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199710000-00002 · Cited by 91 · see citing works

Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans.

Wikberg, T., Vuorela, A., Ottoila, P., et al. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07341-6 · Cited by 90 · see citing works

Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats.

Zürcher, G., Hh, K., Kettler, R., et al. (1990) · PubMed · Cited by 89 · see citing works

The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on‐off fluctuations.

Hardie, R. J., Malcolm, S., Lees, A., et al. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02913.x · Cited by 87 · see citing works

Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study

Kaakkola, S., & Wurtman, R. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)91003-w · Cited by 86 · see citing works

Indole‐3‐carbinol

Bradlow, H. L., Sepkovic, D. W., TELANG, N. T., et al. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb12121.x · Cited by 83 · see citing works

No Association between Parkinson's Disease and Low-Activity Alleles of CatecholO-Methyltransferase

Hoda, F., Nicholl, D. J., Bennett, P., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1731 · Cited by 83 · see citing works

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease

Myllyl�, V. V., Sotaniemi, K. A., Illi, A., et al. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315512 · Cited by 83 · see citing works

2-METHOXYESTRONE, A NEW METABOLITE OF ESTRADIOL-17β IN MAN

Kraychy, S., & Gallagher, T. F. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70636-4 · Cited by 83 · see citing works

The new biology of steroid hormones

(1992) · General and Comparative Endocrinology · doi:10.1016/0016-6480(92)90037-k · Cited by 82 · see citing works

The human catechol-O-methyltransferase (COMT) gene maps to band q11.2 of chromosome 22 and shows a frequent RFLP with BglI

Winqvist, R., Lundstrom, K. H., Salminen, M., Laatikainen, M., & Ulmanen, I. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000133262 · Cited by 80 · see citing works

The pharmacology of Parkinson's disease: Basic aspects and recent advances

Prada, M. D., Keller, H. H., Pieri, L., et al. (1984) · Cellular and Molecular Life Sciences · doi:10.1007/bf01946641 · Cited by 78 · see citing works

Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.

McLeod, H. L., Fang, L., Luo, X., et al. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22361-8 · Cited by 78 · see citing works

Importance of Correlated Motions in Forming Highly Reactive Near Attack Conformations in Catechol O-Methyltransferase

Lau, E. Y., & Bruice, T. C. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9827447 · Cited by 77 · see citing works

Ascending afferent regulation of rat midbrain dopamine neurons

Kelland, M. D., Freeman, A. S., Rubin, J. R., & Chiodo, L. A. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90121-q · Cited by 77 · see citing works

The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission.

Napolitano, A., Cesura, A. M., & Prada, M. D. (1995) · PubMed · Cited by 75 · see citing works

Inhibition of COMT induces dopamine-dependent natriuresis and inhibition of proximal tubular Na+,K+-ATPase

Eklöf, A., Holtbäck, U., Sundelöf, M., et al. (1997) · Kidney International · doi:10.1038/ki.1997.390 · Cited by 75 · see citing works

Catechol-O-methyltransferase (COMT) in rat brain: immunoelectron microscopic study with an antiserum against rat recombinant COMT protein

Karhunen, T., Tilgmann, C., Ulmanen, I., & Panul, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11337-v · Cited by 75 · see citing works

Ro 40-7592: inhibition of COMT in rat brain and extracerebral tissues

Zürcher, G., Colzi, A., & Prada, M. D. (1990) · Springer eBooks · doi:10.1007/978-3-7091-9113-2_51 · Cited by 74 · see citing works

Catechol-O-methyltransferase activity in human and rat small intestine

Nissinen, E., Tuominen, R. K., Perhoniemi, V. J., & Kaakkola, S. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90330-x · Cited by 74 · see citing works

Lack of association of functional cathechol-O-methyltransferase gene polymorphism in schizophrenia

Strous, R. D., Bark, N. M., Woerner, M. G., & Lachman, H. M. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00474-x · Cited by 74 · see citing works

Structure of the Rat Catechol- O -Methyltransferase Gene: Separate Promoters Are Used to Produce mRNAs for Soluble and Membrane-Bound Forms of the Enzyme

Tenhunen, J., Salminen, M., Jalanko, A., UKKONEN, S., & Ulmanen, I. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.253 · Cited by 74 · see citing works

Catechol-O-methyl Transferase in Epidermis, Dermis and Whole Skin*

Bamshad, J. (1969) · Journal of Investigative Dermatology · doi:10.1038/jid.1969.59 · Cited by 73 · see citing works

Relationship of sleep abnormalities to patient genotypes in Prader-Willi syndrome

Vgontzas, A. N., Kales, A., Seip, J. R., Mascari, M. J., Bixler, E. O., Myers, D. C., Vela‐Bueno, A., & Rogan, P. K. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960920)67:5 · Cited by 73 · see citing works

Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder

Gutiérrez, B., Bertranpetit, J., Guillamat, R., Vallès, V., Arranz, M. J., Kerwin, R., & Fañanás, L. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.113 · Cited by 73 · see citing works

Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462

Schultz, E., & Nissinen, E. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90673-4 · Cited by 72 · see citing works

Effect of One Month's Treatment with Peripherally Acting Catechol-O-methyltransferase Inhibitor, Entacapone, on Pharmacokinetics and Motor Response to Levodopa in Advanced Parkinsonian Patients

Ruottinen, H., & Rinne, U. K. (1996) · Clinical Neuropharmacology · doi:10.1097/00002826-199619030-00004 · Cited by 70 · see citing works

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production

Nissinen, E., Kaheinen, P., Penttilä, K. E., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01431-3 · Cited by 69 · see citing works

Tolcapone

Moreau, J., Borgulya, J., Jenck, F., et al. (1994) · Behavioural Pharmacology · doi:10.1097/00008877-199406000-00012 · Cited by 69 · see citing works

Catechol 0-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats

Liljequist, R., Haapalinna, A., Ahlander, M., Li, Y. H., & Männistö, P. T. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)80989-8 · Cited by 69 · see citing works

Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: Difference in levodopa tolerance

Rivera‐Calimlim, L., & Reilly, D. K. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.116 · Cited by 68 · see citing works

The metabolism of l-DOPA and l-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients

Maruyama, W., Naoi, M., & Narabayashi, H. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00049-4 · Cited by 66 · see citing works

Distinct pharmacological regulation of evoked dopamine efflux in the amygdala and striatum of the rat in vivo

Garris, P. A., & Wightman, R. M. (1995) · Synapse · doi:10.1002/syn.890200311 · Cited by 66 · see citing works

Effects of Catechol‐O‐Methyltransferase Inhibitors and L‐3,4‐Dihydroxyphenylalanine With or Without Carbidopa on Extracellular Dopamine in Rat Striatum

Kaakkola, S., & Wurtman, R. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05831.x · Cited by 66 · see citing works

Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat

Kaakkola, S., M�nnist�, P. T., & Nissinen, E. (1987) · Journal of Neural Transmission · doi:10.1007/bf01244343 · Cited by 65 · see citing works

Extracellular Concentrations of Dopamine and Metabolites in the Rat Caudate After Oral Administration of a Novel Catechol‐O‐Methyltransferase Inhibitor Ro 40–7592

Acquas, E., Carboni, E., de Ree, R. H. A., et al. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08907.x · Cited by 64 · see citing works

The Clinical Picture and Plasma Levodopa Metabolite Profile of Parkinsonian Nonresponders

Rivera‐Calimlim, L. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500160042007 · Cited by 64 · see citing works

Ethnic differences in catechol O-methyltransferase pharmacogenetics: frequency of the codon 108/158 low activity allele is lower in Kenyan than Caucasian or South-west Asian individuals.

McLeod, H. L., Syvänen, A.-C., Githanga, J. N., et al. (1998) · PubMed · Cited by 64 · see citing works

The metabolism of L‐3–0‐methyldopa, aprecursor of dopa in man

Kuruma, I., Bartholini, G., Tissot, R., et al. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971124678 · Cited by 64 · see citing works

Potentiation of the l-Dopa effect in man by the use of catechol-O-methyltransferase inhibitors

Ericsson, A. (1971) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(71)90088-8 · Cited by 63 · see citing works

Multiple-dose clinical pharmacology of the catechol- O -methyl-transferase inhibitor tolcapone in elderly subjects

Dingemanse, J., Jorga, K. M., Zürcher, G., et al. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050068 · Cited by 63 · see citing works

Bioactive 6-Nitronorepinephrine Identified in Mammalian Brain

Shintani, F., Kinoshita, T., Kanba, S., ISHIKAWA, T., Suzuki, E., Sasakawa, N., Kato, R., Asai, M., & Nakaki, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.23.13561 · Cited by 63 · see citing works

Oestradiol 16 alpha-hydroxylase: a risk marker for breast cancer.

Bradlow, H. L., Re, H., & Jf, F. (1986) · PubMed · Cited by 61 · see citing works

Production of rat soluble and membrane-bound catechol O-methyltransferase forms from bifunctional mRNAs

Tenhunen, J., & Ulmanen, I. (1993) · Biochemical Journal · doi:10.1042/bj2960595 · Cited by 59 · see citing works

Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase

Männistö, P. T., Kaakkola, S., Nissinen, E., et al. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90258-5 · Cited by 58 · see citing works

Tolcapone added to levodopa in stable parkinsonian patients: A double‐blind placebo‐controlled study

Dupont, E., Burgunder, J., Findley, L. J. J., et al. (1997) · Movement Disorders · doi:10.1002/mds.870120615 · Cited by 58 · see citing works

Graphical analysis of 6-fluoro-L-dopa trapping: effect of inhibition of catechol-O-methyltransferase.

Holden, J. E., Doudet, D. J., Endres, C. J., Chan, G. L.-Y., Morrison, K., Vingerhoets, F. J. G., Snow, B. J., Pate, B. D., Sossi, V., Buckley, K. R., et al. (1997) · PubMed · Cited by 58 · see citing works

The clinical picture

Lee, R. V. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90142-c · Cited by 57 · see citing works

Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease

Maj, J., Rogóż, Z., Skuza, G., et al. (1990) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260898 · Cited by 57 · see citing works

Effect of Entacapone, a COMP Inhibitor, on the Pharmacokinetics and Metabolism of Levodopa After Administration of Controlled-Release Levodopa-Carbidopa in Volunteers

Ahtila, S., Kaakkola, S., Gordin, A., et al. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199502000-00006 · Cited by 55 · see citing works

Metabolites of 6-[18F]fluoro-L-dopa in human blood.

Firnau, G., Sood, S. K., Chirakal, R. V., et al. (1988) · PubMed · Cited by 55 · see citing works

High-performance liquid chromatography separation of hydroxylated estradiol metabolites: formation of estradiol metabolites by liver microsomes from male and female rats.

Suchar, L. A., Chang, R. L., Rosen, R. T., et al. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24305-1 · Cited by 54 · see citing works

Structure-Based Drug Design

Codding, P. W. (1998) · Springer eBooks · doi:10.1007/978-94-015-9028-0 · Cited by 54 · see citing works

Fluorodopa Positron Emission Tomography with an Inhibitor of Catechol- O -Methyltransferase: Effect of the Plasma 3- O -Methyldopa Fraction on Data Analysis

Ishikawa, T., DHAWAN, V. M., Chaly, T., et al. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00010 · Cited by 53 · see citing works

Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan

Yoritaka, A., Hattori, N., Yoshino, H., et al. (1997) · Journal of Neural Transmission · doi:10.1007/bf01294732 · Cited by 53 · see citing works

The multicomponent analysis of estrogens in urine by ion exchange chromatography and GC-MS—II. Fractionation and quantitation of the main groups of estrogen conjugates

Fotsis, T. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90380-3 · Cited by 53 · see citing works

Simultaneous MAO‐B and COMT inhibition in L ‐dopa‐treated patients with parkinson's disease

Lyytinen, J., Kaakkola, S., Ahtila, S., Tuomainen, P. M., & Teräväinen, H. (1997) · Movement Disorders · doi:10.1002/mds.870120404 · Cited by 52 · see citing works

Ontogenic aspects of liver and kidney catechol‐O‐ methyltransferase sensitivity to tolcapone

Vieira‐Coelho, M. A., & Soares-da-Silva, P. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15220.x · Cited by 52 · see citing works

Inhibition of catechol-O-methyltransferase (COMT) as well as tyrosine and tryptophan hydroxylase by the orally active iron chelator, 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20), in rat brain in vivo

Waldmeier, P. C., Buchle, A.-M., & Steulet, A.-F. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90222-i · Cited by 51 · see citing works

Expression of recombinant soluble and membrane‐bound catechol O‐methyltransferase in eukaryotic cells and identification of the respective enzymes in rat brain

Tilgmann, C., Melén, K., Lundstrom, K. H., Jalanko, A., Julkunen, I., Kalkkinen, N., & Ulmanen, I. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17112.x · Cited by 50 · see citing works

Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET

Logan, J., Volkow, N. D., Fowler, J. S., Wang, G., Fischman, M. W., Foltin, R. W., Abumrad, N. N., Vitkun, S. A., Gatley, S. J., Pappas, N. R., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199712)27:4 · Cited by 50 · see citing works

Potent COMT inhibition by Ro 40-7592 in the periphery and in the brain. Preclinical and clinical findings.

Zürcher, G., Dingemanse, J., & Prada, M. D. (1993) · PubMed · Cited by 50 · see citing works

The effect of estradiol on catechol-O-methyltransferase activity in rat liver

Cohn, C. K., & Axelrod, J. (1971) · Life Sciences · doi:10.1016/0024-3205(71)90335-3 · Cited by 49 · see citing works

Metabolism of Catecholamines by Catechol‐O‐Methyltransferase in Cells Expressing Recombinant Catecholamine Transporters

Eshleman, A. J., Stewart, E., Evenson, A. K., et al. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041459.x · Cited by 49 · see citing works

Monooxygenase Mediating Catecholestrogen Formation by Rot Anterior Pituitary is an Estrogen-4-Hydroxylose

Bui, Q. D., Neisz, J., & Hershey, M. S. (1989) · Endocrinology · doi:10.1210/endo-124-2-1085 · Cited by 48 · see citing works

G/A1947 polymorphism in catechol‐O‐methyltransferase (COMT) gene in Parkinson's disease

Xie, T., Ho, S. L., Li, L. S. W., & Ma, O. C. K. (1997) · Movement Disorders · doi:10.1002/mds.870120325 · Cited by 48 · see citing works

Antioxidant properties of nitecapone (OR-462)

Suzuki, Y., Tsuchiya, M., Safadi, A., Kagan, V. E., & Packer, L. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90146-8 · Cited by 47 · see citing works

Mammalian small molecule methyltransferases: Their structural and functional features

Fujioka, M. (1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90287-b · Cited by 47 · see citing works

Catechol-O-methyltransferase in vitiligo

Poole, I. C. L., van den Wijngaard, R. M. J. G. J., Smit, N. P. M., et al. (1994) · Archives of Dermatological Research · doi:10.1007/bf00370732 · Cited by 47 · see citing works

Acute Administration of Levodopa-Benserazide and Tolcapone, a COMT Inhibitor, in Parkinsonʼs Disease

Limousin, P. D., Pollak, P., Pfefen, J. P., et al. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199506000-00006 · Cited by 47 · see citing works

A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients

Hauser, R. A., Molho, E., Shale, H. M., et al. (1998) · Movement Disorders · doi:10.1002/mds.870130406 · Cited by 47 · see citing works

The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites.

Zhu, B. T., Roy, D., & Liehr, J. G. (1993) · Endocrinology · doi:10.1210/endo.132.2.8381068 · Cited by 47 · see citing works

[ 18 F]‐6‐Fluorodopa PET scanning in Parkinson's disease after selective COMT inhibition with nitecapone (OR‐462)

Laihinen, A., Rinne, J. O., Rinne, U. K., et al. (1992) · Neurology · doi:10.1212/wnl.42.1.199 · Cited by 46 · see citing works

Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake

Budygin, E. A., Gainetdinov, R. R., Kilpatrick, M., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00084-9 · Cited by 46 · see citing works

Radioimmunoassay of 2-hydroxyestrone

Ball, P., Emons, G., Haupt, O., et al. (1978) · Steroids · doi:10.1016/0039-128x(78)90117-4 · Cited by 46 · see citing works

Effect of a Novel Catechol-O-Methyltransferase Inhibitor, Nitecapone, on the Metabolism of l-Dopa in Healthy Volunteers

Kaakkola, S., Gordin, A., Järvinen, M., et al. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199010000-00005 · Cited by 46 · see citing works

Expression of Functional Membrane‐Bound and Soluble Catechol‐O‐Methyltransferase in Escherichia coli and a Mammalian Cell Line

Malherbe, P., Bertocci, B., Caspers, P., Zürcher, G., & Prada, M. D. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10054.x · Cited by 45 · see citing works

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020 · see citing works

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction

Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409 · see citing works

Catechol <i>O</i> -methyltransferase <i>val</i> ^<i>158</i> <i>-met</i> genotype and individual variation in the brain response to amphetamine

Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893 · see citing works

The Neurodevelopmental Hypothesis of Schizophrenia, Revisited

Fatemi, S. H., & Folsom, T. D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn187 · Cited by 860 · see citing works

Human Catechol- <i>O</i> -Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary Structure

Nackley, A. G., Shabalina, S. A., Tchivileva, I. E., Satterfield, K., Korchynskyi, O., Makarov, S. S., Maixner, W., & Diatchenko, L. (2006) · Science · doi:10.1126/science.1131262 · Cited by 848 · see citing works

Catechol- <i>O</i> -Methyltransferase Genotype and Dopamine Regulation in the Human Brain

Akil, M., Kolachana, B. S., Rothmond, D. A., Hyde, T. M., Weinberger, D. R., & Kleinman, J. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02008.2003 · Cited by 325 · see citing works

Tolcapone improves cognition and cortical information processing in normal human subjects

Apud, J. A., Mattay, V., Chen, J., Kolachana, B. S., Callicott, J. H., Rasetti, R., Alce, G., Iudicello, J. E., Akbar, N., Egan, M. F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301227 · Cited by 242 · see citing works

Reinforcement learning in depression: a review of computational research

Chen, C., Takahashi, T., Nakagawa, S., Inoue, T., & Kusumi, I. (2015) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.005 · Cited by 233 · see citing works

Mining the Unknown: A Systems Approach to Metabolite Identification Combining Genetic and Metabolic Information

Krumsiek, J., Suhre, K., Evans, A. M., Mitchell, M. W., Mohney, R. P., Milburn, M. V., Wägele, B., Römisch-Margl, W., Illig, T., Adamski, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003005 · Cited by 197 · see citing works

Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications.

Medina, M. Á., Urdiales, J. L., Rodríguez-Caso, C., Ramírez, F. J., & Sánchez-Jiménez, F. (2003) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/713609209 · Cited by 198 · see citing works

Catechol-o-Methyltransferase Enzyme Activity and Protein Expression in Human Prefrontal Cortex across the Postnatal Lifespan

Tunbridge, E., Weickert, C., Kleinman, J., Herman, M., Chen, J., Kolachana, B., Harrison, P., & Weinberger, D. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl032 · Cited by 197 · see citing works

Influence of the COMT genotype on working memory and brain activity changes during development

Dumontheil, I., Roggeman, C., Ziermans, T., Peyrard-Janvid, M., Matsson, H., Kere, J., & Klingberg, T. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.027 · Cited by 165 · see citing works

The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression

Dempster, E. L., Mill, J., Craig, I. W., & Collier, D. A. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-10 · Cited by 129 · see citing works

From an Executive Network to Executive Control: A Computational Model of the<i>n</i>-back Task

Chatham, C. H., Herd, S. A., Brant, A. M., Hazy, T. E., Miyake, A., O'Reilly, R., & Friedman, N. P. (2011) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00047 · Cited by 115 · see citing works

Pharmacogenetics of antidepressants

Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00006 · Cited by 113 · see citing works

Influence of SLC6A3 and COMT variation on neural activation during response inhibition

Congdon, E., Constable, R. T., Lesch, K. P., & Canli, T. (2009) · Biological Psychology · doi:10.1016/j.biopsycho.2009.03.005 · Cited by 103 · see citing works

Attention-Deficit/Hyperactivity Disorder Pharmacogenomics

McGough, J. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.021 · Cited by 92 · see citing works

The effect of moderate acute psychological stress on working memory-related neural activity is modulated by a genetic variation in catecholaminergic function in humans

Qin, S., Cousijn, H., Rijpkema, M., Luo, J., Franke, B., Hermans, E. J., & Fernández, G. (2012) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2012.00016 · Cited by 83 · see citing works

Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood

Nemoda, Z., Szekely, A., & Sasvari-Szekely, M. (2011) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.002 · Cited by 78 · see citing works

Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT

Hevir, N., Šinkovec, J., & Rižner, T. L. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.09.011 · Cited by 69 · see citing works

Study of the Catechol‐O‐Methyltransferase (COMT) Gene with High Aggression in Children

Hirata, Y., Zai, C. C., Nowrouzi, B., Beitchman, J. H., & Kennedy, J. L. (2013) · Aggressive Behavior · doi:10.1002/ab.21448 · Cited by 65 · see citing works

The gut-liver axis

Visschers, R. G. J., Luyer, M. D., Schaap, F. G., Olde Damink, S. W. M., & Soeters, P. B. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32836410a4 · Cited by 60 · see citing works

Association Between Hypnotizability and the Catechol-O-Methyltransferase (COMT) Polymorphism

Szekely, A., Kovacs-Nagy, R., Bányai, É. I., Gősi-Greguss, A. C., Varga, K., Halmai, Z., Ronai, Z., & Sasvari-Szekely, M. (2010) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207141003760827 · Cited by 53 · see citing works

Met158 variant of the catechol-O-methyltransferase genotype is associated with thicker cortex in adult brain

Cerasa, A., Cherubini, A., Quattrone, A., Gioia, M. C., Tarantino, P., Annesi, G., Assogna, F., Caltagirone, C., & Spalletta, G. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.040 · Cited by 34 · see citing works

Catechol-O-methyltransferase modulation of cortisol secretion in psychiatrically at-risk and healthy adolescents

Walder, D. J., Trotman, H. D., Cubells, J. F., Brasfield, J., Tang, Y.-L., & Walker, E. F. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32833a1ff3 · Cited by 34 · see citing works

Dopamine and cognitive control: Sex-by-genotype interactions influence the capacity to switch attention

Gurvich, C., & Rossell, S. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.045 · Cited by 33 · see citing works

Lesion of the Cerebellar Noradrenergic Innervation Enhances the Harmaline-Induced Tremor in Rats

Kolasiewicz, W., Kuter, K., Nowak, P., Pastuszka, A., & Ossowska, K. (2011) · The Cerebellum · doi:10.1007/s12311-011-0250-9 · Cited by 14 · see citing works

The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry

Montel Hayes, R., Mason, C. E., & Miller, J. J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1671122 · Cited by 5 · see citing works

A sensitive radioenzymatic assay for catechol drugs

Durrett, L. R., & Ziegler, M. G. (1980) · Journal of Neuroscience Research · doi:10.1002/jnr.490050613 · Cited by 98 · see citing works

An Abnormal Methylation Ratio Induces Hypomethylation In Vitro in the Brain of Pig and Man, But Not in Rat

McKeever, M., Molloy, A. M., Weir, D. G., et al. (1995) · Clinical Science · doi:10.1042/cs0880073 · Cited by 32 · see citing works

Methylation of phytohormones by the SABATH methyltransferases

Qu, L., Li, S., & Xing, S. (2010) · Chinese Science Bulletin · doi:10.1007/s11434-010-3245-x · Cited by 17 · see citing works

Structural Insights of Outer Membrane Protein Methyltransferases from Rickettsia

Abeykoon, A. H., Noinaj, N., Chao, C., et al. (2013) · The FASEB Journal · doi:10.1096/fasebj.27.1_supplement.561.7

A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols

Ovaska, M., & Yliniemelä, A. (1998) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1007965026738 · Cited by 17 · see citing works